Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping

Autor: A Antela, Coral García Vallecillos, Leopoldo Muñoz Moreno, Fernando Montolio, Hortensia Álvarez, M Casadellà, Irene Portilla, Bibiana Planas, Félix Gutiérrez, Daniel Podzamczer, Sergio Padilla, R Paredes, Arkaitz Imaz, María Pilar Carmona, Maria Casadellà, Alfredo Rodríguez, M Montero-Alonso, Xabier Kortajarena, Isabel Bravo, M Masiá, Adria Curran, J Navarro, Antonio Ocampo, P Carmona-Oyaga, Vicente Boix, Marc Noguera-Julian, M Noguera-Julian, J R Santos, L Pérez-Martínez, J Sanz, Josean A Iribarren, Jordi Navarro, M J Vivancos, Anna Chamorro, Maialen Ibarguren, Celia Miralles, Juan José Ramos González, José Hernández Quero, Esperanza Merino, Cristina Miranda, A Imaz, Pilar Barrufet, Jèssica Muñoz Rodríguez, N Valcarce-Pardeiro, Maria Gracia Mateo, Lluís Force, Ángela Gutiérrez Liarte, A Ocampo, L Muñoz-Medina, Joaquín Portilla, José Ramón Blanco, Livia Giner, P Domingo, P Barrufet, Ana Mariño, Laura Pérez-Martínez, J Pasquau, Diego Torrús, María del, José R. Santos, Araceli Adsuar, Santiago Moreno, Ana Gómez Berrocal, Ariadna Torrella, Jesús Sanz, Melissa Carreres, Nieves Valcarce Pardeiro, Juan Pasquau, Hernando Knobel, Mar Masiá, Marta Montero-Alonso, J Villar-García, Sergio Reus, Catalina Robledano, J Portilla, Rafael Micán, Judit Villar-García, Antonio Antela, R Micán-Rivera, Pere Domingo, María J Pérez-Elías, Roger Paredes, Fernando Dronda, María Jesús Vivancos, Mar Gutierrez, Marcos Diez

Publikováno v: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

BackgroundTransmission of resistance mutations to integrase strand transfer inhibitors (INSTIs) in HIV-infected patients may compromise the efficacy of first-line antiretroviral regimens currently recommended worldwide. Continued surveillance of tran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4e2dc05aedd698e9a07aa5208c40336
https://doi.org/10.1093/jac/dkaa349

PKP-001 Tacrolimus plasma levels in adults during haematopoietic stem cell allotransplantation

Autor: MT Artola Urain, G Liceaga Cundin, M Umerez Igartua, O Valbuena Pascual, JJ Ferreiro Martinez, P Carmona Oyaga, I Fernandez Gonzalez, MP Bachiller Cacho, J Barral Juez, A Asensio Bermejo

Publikováno v: European Journal of Hospital Pharmacy. 21:A136.2-A137

Background When an unrelated donor is used for an allogeneic hematopoietic stem cell transplant (AlloHSCT) highly immunosuppressive treatment is needed during the early post-transplant period as prophylaxis against acute graft versus host disease (aG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ec8aafd1c5ba9be045ce863fdc00e49
https://doi.org/10.1136/ejhpharm-2013-000436.336

CPC-014 Analysis of Antiretroviral Therapy in Adult HIV Patients in a Tertiary Hospital

Autor: A Aranguren Redondo, B. Odriozola Cincunegui, JA Iribarren Loyarte, G Lopez Arzoz, O Valbuena Pascual, MP Bachiller Cacho, P Carmona Oyaga, P Pascual Gonzalez, MJ Gayan Lera, K Andueza Granados

Publikováno v: European Journal of Hospital Pharmacy. 20:A170.2-A170

Background Current guidelines (GESIDA/PNS-2012) for antiretroviral therapy (ART) in adults recommend the combination of 3 drugs for the treatment of chronic HIV infection. Purpose To analyse the ART in adult HIV- infected patients monitored in our ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::673b8dbb0d7af783c6fbe7dc76db9e1b
https://doi.org/10.1136/ejhpharm-2013-000276.471

CPC-100 Pharmaceutical Care in Patients Diagnosed with Multiple Myeloma Treated with Lenalidomide

Autor: I Fernandez Gonzalez, MP Bachiller Cacho, M Iglesias Gaspar, P Pascual Gonzalez, M Umerez Igartua, O Valbuena Pascual, P Carmona Oyaga, G Lizeaga Cundin, J Barral Juez, A Asensio Bermejo

Publikováno v: European Journal of Hospital Pharmacy. 20:A201.1-A201

Background Multiple myeloma (MM) is a malignant monoclonal gammapathy that occurs mainly in patients over 65 years. Lenalidomide is indicated in combination with dexamethasone for the treatment of MM in patients who have received at least one prior t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9653244b30b06cb7787d218b8379484
https://doi.org/10.1136/ejhpharm-2013-000276.557

Haemoglobin levels in patients with anaemia associated with chronic renal failure in predialysis, treated with subcutaneous erythropoietin

Autor: P. Martín Andrés, MJ Gayan Lera, L Gómez de Segura Iriarte, P Carmona Oyaga, L Leunda Eizmendi, E. Esnaola Barrena, J Barral Juez, A Asensio Bermejo, P Pascual Gonzalez, I. Aranguren Ruiz

Publikováno v: European Journal of Hospital Pharmacy. 19:112.3-113

Background It is necessary to monitor the effect of erythropoietin (EPO) on haemoglobin (Hb) levels to check the efficacy and safety of the medicine. The desirable therapeutic range of Hb according to the product information is from 10 to 12 g/dl and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd2ce1716d2c8aa8dd1fcc1249af3323
https://doi.org/10.1136/ejhpharm-2012-000074.73